Lastly, a transcriptomic gene pair was identified as a prognostic biomarker for GC by analyzing the differentially expressed mRNAs (DEmRNAs) and differentially expressed lncRNAs (DElncRNAs) associated with FAT2 mutations. The gene discussed is FAT2; the disease is gastric cancer.